Small Molecule API Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
SMALL MOLECULE API MARKET ANALYSIS

• Small Molecule API Market - Global Forecast to
  2026, by API Type (Artificial, and Natural), by
  Category (Analgesic, Anesthetics,
  Anticonvulsants, Antimetabolites, Antibacterial,
  Alkylating Agents, and Others), and by Region
  (North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa) - Size, Share,
  Outlook, and Opportunity Analysis, 2018- 2026
• A Small molecule Active Pharmaceutical Ingredient
  (API) is a low molecular weight organic compound,
  which may help to control biological process,
  with a size on the order of 1 nm. Most of the
  small molecule can be administered orally and are
  most likely to be absorbed by the body. Owing to
  its small size it has properties of rapid
  diffusibility to reach at intracellular site of
  action.

3
Small Molecule API Market Dynamics

• The Small Molecule API Market is witnessing rapid
  growth due to increasing number of corporate
  agreements. For instance, BASF Pharma will sell
  its OMEGA 3 manufacturing facility in Norway to
  Marine Ingredients. The Highly Potent Active
  Pharmaceutical Ingredients (HPAPI) is projected
  to witness high growth rate, owing to easy access
  to the people for medication in emerging
  economies.
• The rising prevalence of diseases such as cancer,
  cardiovascular, and infectious diseases is
  expected to propel demand for manufacturing of
  small molecule APIs. According to the National
  Center for Biotechnology Information (NCBI)
  report, in 2014, out of 570,341 deaths 29.4 were
  due to cancer and 27.1 were due to
  cardiovascular disease. Increasing consumer
  awareness, benefits of small molecule API, expiry
  of patents covering the top-selling
  pharmaceuticals, and technological advancement in
  manufacturing sector are expected to drive the
  market growth over the forecast period.
• Increasing adoption of generic drugs has resulted
  into affordable healthcare expenditure, which is
  expected to increase production of small molecule
  APIs, in turn driving the global small molecule
  API market growth. According to the Indian Brand
  Equity Foundation (IBEF), in 2018, India is
  largest producer of generic medicines, which
  supplies 50 of vaccines and 40 of drugs to the
  U.S. and 25 of drugs to the U.K.

4
Small Molecule API Market Regional insights

• North America held the largest market share for
  small molecule API registering for 38.84 in
  2017, due to high adoption rate of accelerated
  regulatory review of innovative medicines. Asia
  Pacific excluding Japan (APEJ) market is
  estimated to witness rapid growth in market,
  owing to high adoption of over the counter (OTC)
  drugs by large patient population coupled with
  growing healthcare and pharmaceutical industry
  and strong research and development in API.
  According to IBEF, investment in research and
  development by Indian pharmaceutical companies
  increased (in term of sales) from 5.3 to 8.5
  from 2012 to 2018.

5
Small Molecule API Market Competitive landscape

• The major player operating in global small
  molecule API market include ALLERGAN, Aurobindo
  Pharma, Cambrex Corporation, Albemarle
  Corporation, D.r. Reddys Laboratories Ltd. The
  other key players in market are Johnson Matthey,
  Siegfried Holding AG, Pfizer, Sanofi S.A.,
  Novartis AG, Johnson Johnson, Bristol-Myers
  Squibb, Bachem Holding AG, Boehringer Ingelheim
  GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline
  PLC, GILEAD Science Inc., Albany Molecular
  Research Inc., Sun Pharmaceuticals, AstraZeneca,
  Merck Co, Inc., BASF SE, and Teva
  Pharmaceuticals. In March 2012, the FDA approved
  Ilumya (Tildrakizumab-asmn) developed by Sun
  Pharmaceuticals used for Plaque Psoriasis.

6
Global Small Molecule API - Market Taxonomy

• On the basis of API type, the global small
  molecule API market is segmented into
• Synthetic
• Biological
• On the basis of application, the global small
  molecule API market is segmented into
• Oncology
• Neurology
• Metabolic
• Infectious
• Cardiovascular
• On the basis of geography, the global small
  molecule API market is segmented into
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

7

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/small-molecule-api-market-2423

8
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

9
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

10

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/